Evidence map›Paper›PMID 37282823›Full record

ArticleClinical and translational medicine2023

Post-operative minimal residual disease models to study metastatic relapse in soft-tissue sarcoma patient-derived xenografts.

Suzanne Fischer, David Creytens, Sofie De Geyter, Elly De Vlieghere, Piet Pattyn, Sarah-Lee Bekaert, Kaat Durinck, Nadine Van Roy, An Hendrix, Lore Lapeire and 2 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Suzanne FischerLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.ORCID https://orcid.org/0000-0002-1714-556X
David CreytensCancer Research Institute Ghent, Ghent, Belgium.
Sofie De GeyterLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Elly De VlieghereLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Piet PattynDepartment of Gastro-Intestinal Surgery, Ghent University Hospital, Ghent, Belgium.
Sarah-Lee BekaertCancer Research Institute Ghent, Ghent, Belgium.
Kaat DurinckCancer Research Institute Ghent, Ghent, Belgium.
Nadine Van RoyCancer Research Institute Ghent, Ghent, Belgium.
An HendrixLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.
Lore LapeireCancer Research Institute Ghent, Ghent, Belgium.
Gwen SysCancer Research Institute Ghent, Ghent, Belgium.
Olivier De WeverLaboratory of Experimental Cancer Research, Department of Human Structure and Repair, Ghent University, Ghent, Belgium.ORCID https://orcid.org/0000-0002-5453-760X
Ghent University Hospital · BEGhent University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

SarcomaSoft Tissue NeoplasmsAnimalsDisease Models, AnimalHeterograftsHumansNeoplasm Recurrence, LocalNeoplasm, Residual

Identifiers

PMID37282823
PMCPMC10244893
OpenAlexW4379598643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.